Extended Access of Momelotinib in Adults With Myelofibrosis
GlaxoSmithKline
GlaxoSmithKline
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
Incyte Corporation
iOnctura
Novartis
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Dana-Farber Cancer Institute
University Health Network, Toronto